Predicting the mechanism of phospholipidosis

Journal of Cheminformatics

Volumn 4, Issue 1, 2012, Pages

  Lowe, Robert ^a   Mussa, Hamse Y ^a   Nigsch, Florian ^b   Glen, Robert C ^a   Mitchell, John B O ^c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^c UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862651254     PISSN: None     EISSN: 17582946     Source Type: Journal    
DOI: 10.1186/1758-2946-4-2     Document Type: Article

References (24)

1. Nelson A, Fitzhugh O: Chloroquine: Pathological changes observed in rats which for two years had been fed various proportions. Arch Pathol 1948, 45:454-462.
2. Hostetler K, Matsuzawa Y: Studies on the mechanism of drug-induced lipidosis: Cationic amphiphilic drug inhibition of lysosomal phospholipases A and C. Biochem Pharmacol 1981, 30:1121-1126. (Pubitemid 11105600)
3. Hiraoka M, Abe A, Lu Y, Yang K, Han X, Gross RW, Shayman JA: Lysosomal Phospholipase A2 and Phospholipidosis. Mol Cell Biol 2006, 26:6139-6148. (Pubitemid 44204532)
4. Reasor MJ, Kacew S: Drug-Induced Phospholipidosis: Are There Functional Consequences? Exp Biol Med 2001, 226:825-830. (Pubitemid 34053231)
5. Joshi U, Kodavanti P, Coudert B, Dwyer T, Mehendale H: Types of interaction of amphiphilic drugs with phospholipid vesicles. J Pharmacol Exp Ther 1988, 246:150-157.
6. Abe A, Hiraoka M, Shayman J: A role for lysosomal phospholipase A2 in drug induced phospholipidosis. Drug Metab Lett 2007, 1:49-53.
7. Hirode M, Ono A, Miyagishima T, Nagao T, Ohno Y, Urushidani T: Gene expression profiling in rat liver treated with compounds inducing phospholipidosis. Toxicol Appl Pharmacol 2008, 229:290-299.
8. Eichberg J, Gates J, Hauser G: The mechanism of modification by propranolol of the metabolism of phosphatidyl-CMP (CDP-diacylglycerol) and other lipids in the rat pineal gland. Biochim Biophys Acta 1979, 573:90-106. (Pubitemid 9156935)
9. Pappu A, Hostetler KY: Effect of cationic amphiphilic drugs on the hydrolysis of acidic and neutral phospholipids by liver lysosomal phospholipase A. Biochem Pharmacol 1984, 33:1639-1644. (Pubitemid 14147790)
10. Halliwell WH: Cationic Amphiphilic Drug-Induced Phospholipidosis. Toxicol Pathol 1997, 25:53-60. (Pubitemid 27100559)
11. Sawada H, Takami K, Asahi S: A toxicogenomic approach to drug-induced phospholipidosis: Analysis of its induction mechanism and establishment of a novel in vitro screening system. Toxicol Sci 2005, 83:282-292. (Pubitemid 40227898)
12. Ploemen J P P, Kelder J, Hafmans T, van de Sandt H, van Burgsteden JA, Saleminki PJ, van Esch E: Use of physicochemical calculation of pKa and ClogP to predict phospholipidosis-inducing potential: A case study with structurally related piperazines. Exp Toxicol Pathol 2004, 55:347-355 (Pubitemid 38425469)
13. Tomizawa K, Sugano K, Yamada H, Horii I: Physicochemical and cell-based approach for early screening of phospholipidosis-inducing potential. J Toxicol Sci 2006, 31:315-324. (Pubitemid 44730413)
14. Pelletier DJ, Gehlhaar D, Tilloy-Ellul A, Johnson TO, Greene N: Evaluation of a Published in Silico Model and Construction of a Novel Bayesian Model for Predicting Phospholipidosis Inducing Potential. J Chem Inf Model 2007, 47:1196-1205. (Pubitemid 46973733)
15. Lowe R, Glen RC, Mitchell J B O: Predicting Phospholipidosis Using Machine Learning. Mol Pharmaceutics 2010, 7:1708-1718.
16. Warr WA: Chembl. An interview with John Overington, team leader, chemogenomics at the European Bioinformatics Institute Outstation of the European Molecular Biology Laboratory (EMBL-EBI). J Comput Aided Mol Des 2009, 23:195-198.
17. Glen RC, Bender A, Arnby CH, Carlsson L, Boyer S, Smith J: Circular Fingerprints: Flexible molecular descriptors with applications from physical chemistry to ADME. Drugs 2006, 9:199-204
18. Parzen E: On Estimation of a Probability Density Function and Mode. Annals of Mathematical Statistics 1962, 33:1065-1076.
19. Nigsch F, Bender A, Jenkins JL, Mitchell J B O: Ligand-Target Prediction using Winnow and Naive Bayesian Algorithms and the Implications of Overall Performance Statistics. J Chem Inf Model 2008, 48:2313-2325
20. Kruhlak NL, Choi SS, Contrera JF, Weaver JL, Willard JM, Hastings KL, Sancilio LF: Development of a Phospholipidosis Database and Predictive Quantitative Structure-Activity Relationship (QSAR) Models. Toxicol Mech Methods 2008, 18:217-227. (Pubitemid 351414975)
21. Tatsumi M, Groshan K, Blakely RD, Richelson E: Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 1997, 340:249-258. (Pubitemid 28022649)
22. Schneider PB, Kennedy EP: Sphingomyelinase in normal human spleens and in spleens from subjects with Niemann-Pick disease. J Lipid Res 1967, 8:202-209.
23. Smalla B, Barone L, Valentin JP, Pollard C, Ciaccio P: A comparison between compound potency in an in vitro phospholipidosis assay and at the hERG-encoded potassium channel. J Pharmacol Toxicol Methods 2007, 56:e70.
24. Ryrfeldt A: Drug-induced inflammatory responses to the lung. Toxicol Lett 2000, 112-113:171-176. (Pubitemid 30138120)